680 likes | 1.81k Views
Why does dentistry wait for periodontal damage before initiating treatment of periodontal disease?. Why has early diagnosis and treatment of periodontal disease become so important?. 4.
E N D
4. 4 “A Real Wake-up Call !”Diane Sawyer & Tim Johnson, M.D. 64% increase risk for Pancreatic Cancer
Inflammation & Bacteria that can get into your Blood Stream
The One Symptom: Blood
If you have Bleeding: a sign of of Serious Disease
It IS a Disease
See your dentist & hygienists twice per year or more
Tx will require antibiotics: topically & systemically
5. 5 “The Silent Epidemic”
U.S. Population
74% - Perio. Infection AGD 2002
80% - Mild to Moderate ADA 2006
90% - Age 55-64: M - S AAP J Perio. Aug. 2005, 1408
David Satcher, MD, Surgeon General
6. 6 NIH NEWS … Perio Pathogens, Stroke & Heart Attack
“These data mark first report of a direct association between CVD and bacteria involved in periodontal disease.”
“Older Americans with higher proportions of four periodontal disease causing bacteria (A.a, P.g., T.f., P.i.) tend to have thicker carotid arteries, a strong predictor of stroke and heart attack.”
Feb. issue of Circulation & supported by four agencies of NIH. Feb.7, 2005
7. 7 Acute Coronary Syndrome “The presence of specific bacteria and combinations of bacteria in periodontal pockets ….the findings suggest that T. denticola, T. forsythia and streptococci spp are bacteria in a shared infectious etiology for periodontitis and Acute Coronary Syndrome (ACS).” “Bacterial Profile and Burden of Periodontal Infection in Subjects with a Diagnosis of Acute Coronary Syndrome” J Periodont Aug. 2006
Red Complex: “Consensus Pathogens”
8. 8 Oral / Systemic Connection Heart Disease: 700 % > risk
Fatal CHD: 50% > risk
Stroke: 300% > risk
Pre-Term Birth: 700% > risk
Diabetes: > risk
Rheumatoid Arthritis: > risk
Aspiration Pneumonia: > risk for death
Organ transplants: > risk for failure
Cancer: OSC & Pancreatic
9. Periodontal InflammationsSystemic Effects Myocardial Infarction Brit Med J 298:779, 1989
10. 10 Oral infections and systemic disease- an emerging problem in medicine Clin Microbiol Infect 2007 Nov;13(11):1041-7 “The relationship between oral health and general health has been increasingly recognised during the past two decades. Several epidemiological studies have linked poor oral health with cardiovascular disease, poor glycemic control in diabetics, low birth-weight pre-term babies, and a number of other conditions including rheumatoid arthritis and osteoporosis.”
11. 11 Anders Holmlund, Gunnar Holm, Lars Lind. Severity of Periodontal
Disease and Number of Remaining Teeth Are Related to the Prevalence of Myocardial Infarction and Hypertension in a Study Based on 4,254 Subjects.
Journal of Periodontology 2006, Vol. 77, No. 7, Pages 1173-1178
12. 12 American Heart Journal Volume 154, Issue 6, December 2007, Pages 1086-1094
The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE-PCS)
13. 13 Inflammation Associate With Incident Cardiovascular Disease Events
Pirkko J. Pussinen; Karolina Tuomisto; Pekka Jousilahti; Aki S. Havulinna; Jouko Sundvall; Veikko Salomaa
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:1433.
14. 14 Inflammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study.
Ford PJ, Gemmell E, Chan A, Carter CL, Walker PJ, Bird PS, West MJ, Cullinan MP, Seymour GJ.
Oral Biology and Pathology, School of Dentistry, The University of Queensland, Brisbane, Australia. p.ford@uq.edu.au
15. 15
Chronic Inflammatory Autoimmune Disorders and Atherosclerosis
Authors: ABOU-RAYA, S.1; ABOU-RAYA, A.2; NAIM, A.3; ABUELKHEIR, H.4
Source: Annals of the New York Academy of Sciences, Volume 1107,
Number 1, June 2007 , pp. 56-67(12)
16. 16 Prim Dent Care. 2007 Apr;14(2):59-66. Links
Cardiovascular and oral disease interactions: what is the evidence?
Ford PJ, Yamazaki K, Seymour GJ.
Oral Biology and Pathology, University of Queensland, Brisbane, Australia. p.ford@uq.edu.au
17. 17
J Med Microbiol 54 (2005), 93-96; DOI: 10.1099/jmm.0.45845-0
Molecular detection of Treponema denticola and Porphyromonas gingivalis in carotid and aorticatheromatous plaques
18. 18 Ross R, Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115- 126
Ridker PM. Evaluating novel cardiovascular risk factors: can we
better predict heart attacks? Ann Intern Med. 1999;130:933 937.
19. 19 Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? J Circulation.
1999;100:96 102.(Abstract)
20. 20 Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project.
Arterioscler ThrombVasc Biol. 1997;17:1121 1127
21. 21 Partial Literature Source Summary Arteriosclerosis, Thrombosis, and Vascular Biology Journal
Journal of Clinical Microbiology & Infection
American Heart Journal
Journal of Periodontology
Annals of the NY Academy of Sciences
Primary Dental Care
Journal of Medical Microbiology
New England Journal of Medicine
Journal of Circulation
American Journal of Epidemiology
American Journal of Medicine
British Medical Journal
22. 22 Thanks to Dr Bill Domb for his research
24. Traditional Assessment Can traditional tests detect pathogenic biofilms?
25. Traditional Diagnostic Tests Historical Legacy Techniques
26. Disclosing Solution & Plaque Indices Only measure supragingival plaque. (typically Gram (+) & aerobic ? i.e. health)
Cannot differentiate between pathogenic & non-pathogenic biofilms
Mostly useful for patient motivation
27. Radiographs Mostly ID historical damage
Cannot identify pathogenic risk factors
28. Pocket Depth: The Bottom Line The pocket is not the disease. It is a result of disease, not the cause.
29. Bleeding on ProbingNot Correlated with Disease
30. BOP ? Common Drug Effects Hypertension ~ 25% of adults take Rx BP medications, most of which increase capillary fragility
Aspirin 325 mg daily / 7 days 12.4% Increase in BOP
31. Pocket Depth Review Cannot distinguish between high & low risk infections
Not predictive
Identifies historical disease sites
Fraught with measurement error
33. New Diagnostic Paradigm Identify the presence of pathogenic bacteria in the sulcular fluid
34. New Treatment Paradigm Antimicrobial therapy specific for the identified pathogens
35. Phase Contrast Video Microscopy
Chairside
Fast: 2 minutes
Cheap: 25¢ / test
ID’s: Morphotypes Spirochetes WBC’s Protozoans
Antibiotic Verification (efficacy/compliance)
Patient Motivation!
36. Phase Contrast Video Microscopy Disadvantages
Initial cost: $3-7 K
No antibiotic specificity
Unfamiliar technology
37. What Microbiota is Consistent withPeriodontal ?
38. What Microbiota is Consistent withPeriodontal ?
39. Treponema (spirochetes)
40. Red group +
8 Additional Pathogens
Antibiotic Specificity
Diagrammatic Pt. Chart
Independent Lab Micro-IDent Plus
41. Micro-IDent Plus Comparison of the two methods revealed that the Micro-IDent kit identified both P. gingivalis and B. forsythus more often than did the cultivation method.
42. Micro-IDent Plus Conclusions: Nucleic acid techniques should replace cultivation methods as the gold standard in microbiological diagnosis of progressive periodontitis.
43. PeriodontitisPredominant Microbial Species Gram-Negative Anaerobic Species
44. 44 DNA-PCR TESTING …
45. 45
46. 46
47. Micro-IDent (report detail)
48. 48 Do we really realize ….? The implications of the Oral/Systemic Connection for our patients
The significant health impact that only WE can make
The Financial Impact the Oral / Systemic Connection can have …
49. 49 “Clearly, it will be critical that medical students, dental students, nursing students and public health students be educated about the significance of oral disease as it relates to systemic disease and about some of the things we can do to intervene.” David Satcher, M.D.,2000:U.S. Surgeon General; Oral and Whole Body Health; 40
50. 50
51. 51 Periodontal Medicine How DNA is changing our paradigm
52. 52 An entirely new aspect of perio. is currently being born: the strong relation-ship between Oral status & Systemic health.
53. 53 Consequently, a new discipline,
Periodontal Medicine
has emerged in dentistry which seeks to further define these interrelationships …
D.W. Paquette, DMD, MPH, DMSc, J of Cont Dent Pract, Vol. 1, 1-17, 2005
54. 54 * 32% traditional tx fails within 9 months …
A. Haffejee,, J Clin Periodon 1997;24:324-334
* 64% Tx fails over time …
Rosling B, J Clin Periodontol 2001;228:241-249
55. 55 “Keys” to FAILURE… “A poor treatment response …persistence of periodontopathogenic species”
“After treatment, DNA extraction revealed: 86% of patients were positive for pathogenic microorganisms.” J Clin Perio Supp 7, Vol 33, 2006
>32% have Genetic Predisposition for inflammatory infections Korman; J of Period, 1997
56. 56 Something’s wrong with our present Oral Health System … We are treating “Plaque, Calculus & Pockets”
While we should be treating “Wounds” caused by very toxic/virulent organisms
In people that are often Genetically Predisposed and have high risk for Systemic Diseases
57. 57 “Pocket” vs. “Wound” … When the gingival attachment is lost due to the pathogenic bacterial invasion, the body has lost an important protective component. As a result, we have an open, infected wound all the way to bone level. (A true invasive infection)
Why shouldn’t we treat this infected wound using the same medical concepts of other infected wounds?
58. 58 Important Information “…most patients receive essentially the same anti-infective therapy, despite the recognition that subjects differ in the composition of their subgingival microbiotas. The “standard” therapy may be appropriate for the subgingival microbiota in one individual, but not in another.”
“Conceivably, when the most appropriate therapy is matched to a subject’s Specific Microbial Profile, the reductions in the individual's pathogenic complex will be greater and more reproducibly sustained, leading to long-term clinical stability.” Microbiological goals of periodontal therapy; Periodontol 2000; Vol. 42, 2006, 180-218: Teles, Haffajee, Socransky
59. Tissue Invasion Some Species invade gingiva to become partially independent of the original biofilm
Life Below the Gum Line:Pathogenic mechanisms of Porphyromonas gingivalis.
Lamont & JenkinsonMicrobiol & Molecular Biol Rev 62:1244-1263 1998
Ecosystems: Development, functions & consequences
of disturbances with special reference to the oral cavity.
Midtvedt, J Clin Periodontol 19: 348-356 1992
60. Periodontal InflammationsCardiovascular Risk –Why? Biofilm inflammations aresimilar to systemic infections
61. Microbiological AssessmentGenco Recommendations - 1986
Although all specific pathogens have not been defined,a sufficient number of important pathogens are knownand testing for these organisms is, therefore, indicated.
Technologies have been developed to the point whererapid microbiological tests are feasible and practical.
The rationale for (microbial) assessment and the present level of technology making such assessment feasible, strongly supports the use of microbiologic assays as adjuncts in the clinical management of periodontal disease.
62. Finally, in 2003AAP on Microbiological Diagnosis Plaque-induced periodontal diseases are mixed infections associated with relatively specific groups of indigenous oral bacteria.
Susceptibility to these diseases is highly variable and depends on host responses to periodontal pathogens.
Presently, the diagnosis & classification of periodontal diseases are almost entirely based on traditional clinical assessments.
Supplemental quantitative & qualitative assessments of the subgingival microflora can potentially provide useful information about the patient’s periodontal disease [and] may be particularly valuable in establishing the endpoint of therapy.
63. Periodontology 2000 The vast majority of periodontal diseases are caused by microorganisms that reside at or below the gingival margin. The best way to control periodontal infections is to control the pathogenic species residing in these locations.
Actinobacillus actinomycetemcomitans, P. gingivalis & Tannerella forsythia were designated periodontal pathogens at the 1996 World Workshop in Perio.
Since then, evidence for a number of other species, including: Prevotella intermedia, Prevotella melanino-genica, Fusobacterium nucleatum, P. micros, Eubacterium spp., Eikenella corrodens, Prevotella nigrescens and Spirochetes has gotten stronger.
64. Microbial Testing A. actinomycetemcomitans and P. gingivalis cannot be removed from a significant part of deep periodontal lesions by mechanical therapy alone.
Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000 2002: 28: 106–176.
The percentage of A. actinomycetemcomitans and P. gingivalis may even increase following scaling and root planing.
Mombelli A, McNabb H, Lang NP. Black-pigmenting gramnegative bacteria in periodontal disease. II. Screening strategies for detection of P. gingivalis. J Periodontal Res 1991: 26: 308–313.
65. Diagnostic ? Diagnostic Consequences
66. Traditional Periodontal Assessment